ADTX ADITXT INC Company Mergers 8-K Filing 2024 - Acquisition Agreement Aditxt Inc. has entered into an agreement for Adivir, its subsidiary, to acquire Appili Therapeutics, with multiple amendments extending deadlines for completion and financial disclosures, including a $115,000 waiver fee paid to Appili.Get access to all SEC 8-K filings of the ADITXT INC